Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Oct
11
2016
PTAB Upholds Lialda Patent Over Kyle Bass IPR Challenge Foley & Lardner LLP
Jul
27
2020
PTAB Must Give Parties A Chance To Respond To New Grounds Foley & Lardner LLP
Aug
19
2020
PTAB’s Motion to Amend Pilot Program: Review of Initial Results Foley & Lardner LLP
Jan
16
2017
Supreme Court Will Judge Biosimilar Patent Dance Foley & Lardner LLP
Feb
7
2017
Federal Circuit Court Rejects Theory Of Derivation Based On FDA Requirement Foley & Lardner LLP
Dec
15
2020
Arthrex Amicus Briefs – Novel Arguments for the Court To Consider Foley & Lardner LLP
Mar
6
2017
One is Not Enough – Infringement Liability under § 271(f)(1) Foley & Lardner LLP
Dec
30
2020
Arthrex’s Initial Merits Brief – Making the Case for Patent Judges as Principal Officers Foley & Lardner LLP
Feb
9
2021
USPTO Offers Relief for COVID-Related Delays in Submitting Priority Documents Foley & Lardner LLP
Feb
16
2021
The Tools Used in Modern Business---Such As Videoconferencing---and the Social Media Culture Create Real Challenges to Protecting Trade Secrets Foley & Lardner LLP
Mar
24
2015
Supreme Court Holds That TTAB Decisions on Likelihood of Confusion May Bind Courts in Infringement Litigation Foley & Lardner LLP
Nov
9
2021
As Vehicles Become Computerized, NPE Patent Owners Are Targeting Automakers Foley & Lardner LLP
Apr
9
2015
Apotex Has Standing Despite Benicar Patent Disclaimer Foley & Lardner LLP
Apr
21
2015
An In-Depth Look At USPTO Patent Quality Problems Foley & Lardner LLP
Sep
7
2017
FDA Marketing Exclusivity Periods Limited To Same Active Moiety Foley & Lardner LLP
May
19
2015
Federal Circuit Finds No Direct Infringement Of Akamai Patents Foley & Lardner LLP
May
30
2015
Apple v. Samsung: Design Patents Reap Profits Foley & Lardner LLP
Oct
4
2017
CAFC Eases Amendment Process In IPR Proceedings Foley & Lardner LLP
Nov
20
2017
USPTO Patent Fees To Go Up January 2018 Foley & Lardner LLP
Aug
11
2022
Federal Circuit Rules Inventors Must Be Natural Human Beings Foley & Lardner LLP
Feb
6
2018
PTAB Enters Sua Sponte Patent Eligibility Rejections Foley & Lardner LLP
Aug
19
2015
USPTO Proposes Extensive Changes to AIA Post-Grant Proceedings Foley & Lardner LLP
Aug
25
2015
Acquisition of HERE – a Prime Example of How IP Can “Drive” Value Foley & Lardner LLP
Jul
24
2018
CAFC Finds Publication Did Not Inherently Disclose Aveed Composition Foley & Lardner LLP
Aug
14
2018
New USPTO Fees For 2021 Foley & Lardner LLP
Dec
8
2015
Proposed Rule Changes For IPR Appeals Foley & Lardner LLP
Dec
16
2015
Federal Circuit Provides Additional Insight into the Scope of Board Institution-Related Decisions That Are Not Appealable Foley & Lardner LLP
Jul
19
2023
IP Toolbox Is Crucial In AI-Powered Drug Discovery Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins